# Editorial: India's leprosy numbers overshoot targets, two decades after 'elimination'

URL: https://upsc.help/current-affairs/2026-10-07/leprosy-targets-missed-editorial/
Date: 7 October 2026 (2026-10-07)
Source: The Hindu, Editorial
UPSC papers: GS2, GS3
Publisher: upsc.help (Pratidin), free and open-source UPSC Civil Services current affairs. Not affiliated with UPSC. Every fact was checked against the source reports by a separate review before publishing.

**In one line:** India's 2025-26 leprosy data show new cases, child cases and disabilities well above plan, and The Hindu argues that complacency after 2005 is to blame.

An editorial in The Hindu, "Break the chain", argues that India is falling short of its own leprosy goals under the National Strategic Plan and Roadmap for Leprosy 2023-2027. Citing the National Leprosy Eradication Programme's (NLEP) report for 2025-26, it says overall incidence overshot projections by 41%, incidence among children by 91.6% and the grade-2 disability rate by 34%, and that only 148 of the 300 districts projected to achieve "interruption of transmission" did so. The report counts 91,783 new cases in 2025-26, of which 3,832 (4.18%) were children; WHO data put India's share of the world's newly detected child cases at nearly half.

Leprosy is caused by the bacterium Mycobacterium leprae and spreads through droplets during prolonged close contact with untreated patients. It damages the skin, peripheral nerves and eyes, and is curable with multidrug therapy (MDT). Grade-2 disability means visible deformity or damage already present when a case is found; the 2025-26 rate was 1.34 per million against a target of less than one. New cases among children signal recent transmission in the community. Active case finding matters: Leprosy Case Detection Campaigns found 24,367 cases and ASHA-led surveillance confirmed 48,027, about 52% of the year's total.

The editorial traces the problem to complacency after India achieved "elimination as a public health problem" (a prevalence below one case per 10,000 people) in 2005. Folding leprosy services into general health care thinned specialist attention, it argues, and because MDT shortened the time patients stay on the register, low prevalence figures hid continuing transmission. Stigma and late diagnosis, often by doctors unfamiliar with the disease, remain obstacles. It notes the government's move to digital surveillance and its consideration of a vaccine based on Mycobacterium indicus pranii (MIP), and post-exposure prophylaxis that reached 91.1% of 16.9 lakh contacts. Five States, Maharashtra, Chhattisgarh, Jharkhand, Odisha and Madhya Pradesh, account for nearly half of the burden.

## Prelims facts

- India recorded 91,783 new leprosy cases in 2025-26, including 3,832 children (4.18%), according to NLEP data.
- The editorial says incidence overshot projections by 41%, child incidence by 91.6% and the grade-2 disability rate by 34%.
- Only 148 districts achieved interruption of transmission, against 300 projected under the National Strategic Plan 2023-2027.
- India achieved elimination as a public health problem, a prevalence below 1 per 10,000 population, in 2005; prevalence in 2025-26 was 0.56 per 10,000.
- WHO recommends a single dose of rifampicin as post-exposure prophylaxis for close contacts of leprosy patients.

## Quick recall

- **Which bacterium causes leprosy?** Mycobacterium leprae.
- **What does 'elimination as a public health problem' mean for leprosy?** Prevalence below one case per 10,000 population; India reached it in 2005.
- **New leprosy cases in India in 2025-26?** 91,783, of which 3,832 (4.18%) were children.
- **By how much did child incidence overshoot projections in 2025-26?** 91.6%, according to The Hindu's editorial citing NLEP data.
- **How many districts achieved interruption of transmission in 2025-26?** 148, against 300 projected.
- **Which three drugs make up leprosy MDT?** Dapsone, rifampicin and clofazimine.
- **When did the National Leprosy Control Programme become the NLEP?** 1983, after multidrug therapy was introduced.
- **What is WHO's global leprosy strategy for 2021-2030 called?** Towards zero leprosy.

## Prelims practice question

With reference to leprosy in India, consider the following statements:
1. 'Elimination as a public health problem' means a prevalence rate below one case per 10,000 population.
2. The National Leprosy Eradication Programme was earlier known as the National Leprosy Control Programme.
3. A single dose of rifampicin is given to close contacts of patients as post-exposure prophylaxis.
Which of the statements given above are correct?

(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3

Answer: (d) 1, 2 and 3. All three are correct. Elimination is defined as prevalence below 1 per 10,000; India reached it in 2005. The National Leprosy Control Programme of 1954-55 became the NLEP in 1983 after MDT was introduced. Single-dose rifampicin post-exposure prophylaxis is recommended by WHO and used under the NLEP.

## UPSC previous-year questions this connects to

- UPSC Mains 2018, GS2: Appropriate local community level healthcare intervention is a prerequisite to achieve 'Health for All' in India. Explain. (https://upsc.help/pyq/q176-appropriate-local-community-level-healthcare-intervention-prerequisite/)
  How to use this story in the answer: Use leprosy to show that community-level detection by ASHAs and campaigns, not hospital care alone, is what breaks transmission chains.
- UPSC Mains 2021, GS2: "Besides being a moral imperative of Welfare State, primary health structure is a necessary pre-condition for sustainable development." Analyze. (https://upsc.help/pyq/q175-besides-being-moral-imperative-welfare-state-primary/)
  How to use this story in the answer: Show that letting a disease-specific focus fade inside primary care can reverse gains, using leprosy's missed targets.
- UPSC Prelims 2023, Prelims: Consider the following statements: Statement-I: India's public sector health care system largely focuses on curative care with limited preventive, promotive and rehabilitative care. Statement-II: Under India's decentralized approach to health care delivery, the States are primarily responsible for organizing health services. Which one of the following is correct in respect of the above statements? (https://upsc.help/pyq/q178-consider-following-statements-statement-i-india-s-public/)

## Mains practice question

Two decades after India eliminated leprosy as a public health problem, new cases among children are running well above targets. Analyse the reasons and suggest measures to interrupt transmission. (250 words)

### Model answer

India achieved elimination of leprosy as a public health problem (prevalence below 1 per 10,000) in 2005, but the NLEP's 2025-26 data show 91,783 new cases, 3,832 of them children, and child incidence 91.6% above projections.

## Why the targets were missed
- **Complacency after 2005:** elimination was read as the end of the disease, and focus faded.
- **Integration into general health services:** specialist skills thinned; doctors unfamiliar with leprosy diagnose late.
- **Prevalence hides transmission:** MDT shortens time on the register, so low prevalence masked new infections.
- **Long incubation:** symptoms can take up to 20 years to appear, which makes surveillance hard.
- **Stigma:** patients hide symptoms, so disability is already present at detection; the grade-2 disability rate was 34% above projection.
- **Concentration:** five States account for nearly half the burden.

## Measures
- **Track incidence, not just prevalence:** child cases and grade-2 disability are better signals of transmission.
- **Active case finding:** campaigns found 24,367 cases and ASHA-led surveillance confirmed 48,027 in 2025-26; extend them to high-burden districts.
- **Protect contacts:** single-dose rifampicin prophylaxis reached 91.1% of 16.9 lakh contacts; aim for full coverage.
- **New tools:** digital surveillance and a possible MIP-based vaccine.
- **Fight stigma:** train primary care doctors, counsel communities and repeal discriminatory laws, as the NLEP urges States.

## Conclusion
Meeting the national goal of interrupting transmission by 2030 needs leprosy treated as an active epidemic in its remaining pockets, not a solved problem.

## The basics

## Why this matters

Leprosy shows a trap that applies to many public health goals: hitting a target is not the same as ending a disease. For GS2 you need to know what leprosy is, what India's 2005 "elimination" meant, how the programme finds and treats cases, and why the numbers from 2025-26 worry experts.

## The disease

Leprosy and Mycobacterium leprae is an infection of the skin and nerves. It spreads slowly, through droplets during prolonged close contact, and can take up to 20 years to show symptoms. It is curable with multidrug therapy of dapsone, rifampicin and clofazimine taken for 6 or 12 months. Untreated, it damages nerves and leads to disability.

## What 'elimination' meant

In 2005 India brought leprosy prevalence below one case per 10,000 people. That is elimination "as a public health problem", not eradication. The difference between Prevalence and incidence explains why the disease could keep spreading after that date.

## How India fights it

The National Leprosy Eradication Programme finds cases through campaigns and ASHA workers, treats them with free MDT, and protects contacts through Post-exposure prophylaxis with single-dose rifampicin.

## Where the plan fell short

The editorial compares the 2025-26 results with the strategic plan's projections. All three key measures overshot.

## The way forward

Experts quoted in coverage of the report point to poor detection. Reaching the goal of interrupting transmission by 2030 means finding cases earlier, covering every contact and fighting the stigma that keeps patients hidden.

## Sources

- https://superkalam.com/current-affairs/07-10-2026/break-the-chain-pg6-39e19e5f-5576-4066-b9a0-0e066b93f5af
- https://m.thewire.in/article/health/india-saw-3832-new-leprosy-cases-among-children-last-year-nearly-half-of-global-total-report
- https://www.outlookindia.com/healthcare-spotlight/leprosy-lingers-in-indias-pockets-govt-pushes-localised-strategy
- https://www.pib.gov.in/PressReleasePage.aspx?PRID=2174943&reg=3&lang=2
- https://www.who.int/news-room/fact-sheets/detail/leprosy
- https://www.newsbytesapp.com/news/india/india-records-3832-child-leprosy-cases-2025-26-almost-double-target/tldr
